月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
抗癌研究(AR)出版高质量的作品和评论的所有方面的实验和临床癌症研究。AR优先发表促进对癌症病因认识的论文，以及将基础研究成果应用于癌症诊断、预后和治疗的论文。
http://www.iiar-submissions.com/login.html
Anticancer Research (AR) publishes high quality works and reviews on all aspects of experimental and clinical cancer research. AR preferentially publishes papers advancing the understanding of cancer causation, and papers applying the results of basic research to cancer diagnosis, prognosis and therapy.
